The global hepatitis test solution/diagnosis market is expected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period (2018–2023).
Abbott Laboratories (US), Roche Diagnostics (Switzerland), and Siemens Healthineers (Germany) Dominated the Global Hepatitis Test Solution/Diagnosis Market
MarketsandMarkets™ - Oct 29, 2018
